The impact of olanzapine on attitude to medication and quality of life in schizophrenia

Psychiatric Bulletin

Volumn 25, Issue 10, 2001, Pages 378-381

  Stallard, J ^a   Joyce, E ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT; OLANZAPINE;

ADULT; AGE; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYNDROME; FEMALE; GENDER; HUMAN; HYPOTHESIS; MALE; PATIENT ATTITUDE; PRESCRIPTION; QUALITY OF LIFE; SCHIZOPHRENIA; SYMPTOM;

EID: 0034749726     PISSN: 09556036     EISSN: None     Source Type: Journal    
DOI: 10.1192/pb.25.10.378     Document Type: Article

References (13)

1. A rating scale for drug-induced akathisia
2. Results of a double-blind fixed-dose olanzapine trial
3. Olanzapine versus haloperidol and placebo: Acute phase results of North American olanzapine trial
4. Olanzapine versus haloperidol: Acute phase results of the international double-blind olanzapine trial
5. The current status of neuroleptics
6. Clozapine in treatment resistant schizophrenia: A double-blind comparison with chlorpromazine
7. The social care directive: Development of a quality of life profile for use in community services for the mentally ill
8. The Brief Psychiatric Rating Scale
9. A Rating Scale for Extrapyramidal Symptoms
10. Olanzapine versus haloperidol in the treatment of schizophrenia, schizoaffective and schizophreniform disorders: Results of an international collaborative trial
11. Neuroleptic non-compliance in schizophrenia
12. Rating of Medication Influences (ROMI) Scale in schizophrenia